Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
23.96
+0.23 (0.97%)
At close: Aug 14, 2026, 4:00 PM EDT
23.71
-0.26 (-1.06%)
After-hours: Aug 14, 2026, 4:10 PM EDT
Surrozen Market Cap
Surrozen has a market cap or net worth of $281.62 million as of August 14, 2026. Its market cap has increased by 226.63% in one year.
Market Cap
281.62M
Enterprise Value
185.89M
1-Year Change
226.63%
Ranking
Category
Stock Price
$23.96
ChartMarket Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $281.62M, an increase of 133.41%. That is a compound annual growth rate of 16.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 281.62M | 33.66% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 307.47M |
| InflaRx | 296.21M |
| Eledon Pharmaceuticals | 291.43M |
| Bicycle Therapeutics | 284.17M |
| Fulcrum Therapeutics | 283.83M |
| Sionna Therapeutics | 282.58M |
| Lineage Cell Therapeutics | 278.20M |
| ALX Oncology Holdings | 277.94M |